CEACAM5 and colorectal cancer: More recently, however, Zheng et al. identified a novel CEACAM-5 mAb that significantly suppressed cell proliferation, migration and aggregation of colorectal cancer cells in vitro and in vivo either through ADCC or through blocking intercellular interaction between CEACAM-5 on cancer cells and CEACAM-1 on NK cells [66].